The benefits and harms of intravenous thrombolysis with alteplase within 6 h of acute ischaemic stroke
 (the third international stroke trial [IST-3]): a randomised controlled trial.
The IST3 collaborative group
 

Home   Recruitment   Login to Trial Archive    Patients & Carers     Links   Funding   Sponsors